Skip to main content

Advertisement

SpringerLink
Log in

Bone Loss in Rheumatoid Arthritis: Systemic, Periarticular, and Focal

  • OSTEOPOROSIS AND METABOLIC BONE DISEASE (KG SAAG, SECTION EDITOR)
  • Published:
Current Rheumatology Reports Aims and scope Submit manuscript

Abstract

Rheumatoid arthritis is a chronic inflammatory disease that results in generalized bone loss and increased fracture risk. Characteristic radiologic features of rheumatoid arthritis include periarticular osteopenia and marginal erosions. An emerging literature highlights the importance of osteoclasts as mediators of the erosive process, with an impairment of bone formation by inhibition of the Wnt signaling pathway as a cause of lack of repair of erosions. MRI has demonstrated the importance of inflammation in the bone marrow compartment as a cause of periarticular osteopenia. The term osteoimmunology has evolved to highlight the association between cells and cytokines of the immune system and their relationship to bone metabolism in rheumatoid arthritis and other forms of chronic inflammatory arthritis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig 1
Fig 2

Similar content being viewed by others

References

  1. van Staa TP, Geusens P, Bijlsma JW, Leufkens HG, Cooper C. Clinical assessment of the long-term risk of fracture in patients with rheumatoid arthritis. Arthritis Rheum. 2006;54:3104–12.

    Article  PubMed  Google Scholar 

  2. Orstavik RE, Haugeberg G, Uhlig T, et al. Vertebral deformities in 229 female patients with rheumatoid arthritis: associations with clinical variables and bone mineral density. Arthritis Rheum. 2003;49:355–60.

    Article  PubMed  Google Scholar 

  3. Kanis JA, Johnell O, Oden A, Johansson H, McCloskey E. FRAX and the assessment of fracture probability in men and women from the UK. Osteoporos Int. 2008;19:385–97.

    Article  PubMed  CAS  Google Scholar 

  4. Engvall IL, Svensson B, Tengstrand B, Brismar K, Hafstrom I. Better Anti-Rheumatic FarmacO Therapy Study Group. Impact of low-dose prednisolone on bone synthesis and resorption in early rheumatoid arthritis: experiences from a two-year randomized study. Arthritis Res Ther. 2008;10:R128.

    Article  PubMed  Google Scholar 

  5. Wijbrandts CA, Klaasen R, Dijkgraaf MG, Gerlag DM, van Eck-Smit BL, Tak PP. Bone mineral density in rheumatoid arthritis patients 1 year after adalimumab therapy: arrest of bone loss. Ann Rheum Dis. 2009;68:373–6.

    Article  PubMed  CAS  Google Scholar 

  6. Seriolo B, Paolino S, Sulli A, Ferretti V, Cutolo M. Bone metabolism changes during anti-TNF-alpha therapy in patients with active rheumatoid arthritis. Ann N Y Acad Sci. 2006;1069:420–7.

    Article  PubMed  CAS  Google Scholar 

  7. Arron JR, Choi Y. Bone versus immune system. Nature. 2000;408:535–6.

    Article  PubMed  CAS  Google Scholar 

  8. Schett G. Osteoimmunology in rheumatic diseases. Arthritis Res Ther. 2009;11:210.

    Article  PubMed  Google Scholar 

  9. Ritchlin CT, Haas-Smith SA, Li P, Hicks DG, Schwarz EM. Mechanisms of TNF-alpha- and RANKL-mediated osteoclastogenesis and bone resorption in psoriatic arthritis. J Clin Invest. 2003;111:821–31.

    PubMed  CAS  Google Scholar 

  10. Zaiss MM, Axmann R, Zwerina J, et al. Treg cells suppress osteoclast formation: a new link between the immune system and bone. Arthritis Rheum. 2007;56:4104–12.

    Article  PubMed  CAS  Google Scholar 

  11. Vis M, Havaardsholm EA, Haugeberg G, et al. Evaluation of bone mineral density, bone metabolism, osteoprotegerin and receptor activator of the NFkappaB ligand serum levels during treatment with infliximab in patients with rheumatoid arthritis. Ann Rheum Dis. 2006;65:1495–9.

    Article  PubMed  CAS  Google Scholar 

  12. Guler-Yuksel M, Allaart CF, Goekoop-Ruiterman YP, et al. Changes in hand and generalised bone mineral density in patients with recent-onset rheumatoid arthritis. Ann Rheum Dis. 2009;68:330–6.

    Article  PubMed  CAS  Google Scholar 

  13. Dirven L, Guler-Yuksel M, de Beus WM, et al. Changes in hand bone mineral density and the association with the level of disease activity in patients with rheumatoid arthritis: bone mineral density measurements in a multicenter randomized clinical trial. Arthritis Care Res (Hoboken). 2011;63:1691–9.

    Article  CAS  Google Scholar 

  14. Schett G, Kiechl S, Weger S, et al. High-sensitivity C-reactive protein and risk of nontraumatic fractures in the Bruneck study. Arch Intern Med. 2006;166:2495–501.

    Article  PubMed  CAS  Google Scholar 

  15. Weitzmann MN, Pacifici R. Estrogen deficiency and bone loss: an inflammatory tale. J Clin Invest. 2006;116:1186–94.

    Article  PubMed  CAS  Google Scholar 

  16. Charatcharoenwitthaya N, Khosla S, Atkinson EJ, McCready LK, Riggs BL. Effect of blockade of TNF-alpha and interleukin-1 action on bone resorption in early postmenopausal women. J Bone Miner Res. 2007;22:724–9.

    Article  PubMed  CAS  Google Scholar 

  17. Roggia C, Gao Y, Cenci S, et al. Up-regulation of TNF-producing T cells in the bone marrow: a key mechanism by which estrogen deficiency induces bone loss in vivo. Proc Natl Acad Sci U S A. 2001;98:13960–5.

    Article  PubMed  CAS  Google Scholar 

  18. Schett G. Bone marrow edema. Ann N Y Acad Sci. 2009;1154:35–40.

    Article  PubMed  Google Scholar 

  19. McQueen FM. The MRI view of synovitis and tenosynovitis in inflammatory arthritis: implications for diagnosis and management. Ann N Y Acad Sci. 2009;1154:21–34.

    Article  PubMed  Google Scholar 

  20. Jimenez-Boj E, Nobauer-Huhmann I, Hanslik-Schnabel B, et al. Bone erosions and bone marrow edema as defined by magnetic resonance imaging reflect true bone marrow inflammation in rheumatoid arthritis. Arthritis Rheum. 2007;56:1118–24.

    Article  PubMed  Google Scholar 

  21. Schett G, Firestein GS. Mr Outside and Mr Inside: classic and alternative views on the pathogenesis of rheumatoid arthritis. Ann Rheum Dis. 2010;69:787–9.

    Article  PubMed  Google Scholar 

  22. Gravallese EM, Harada Y, Wang JT, Gorn AH, Thornhill TS, Goldring SR. Identification of cell types responsible for bone resorption in rheumatoid arthritis and juvenile rheumatoid arthritis. Am J Pathol. 1998;152:943–51.

    PubMed  CAS  Google Scholar 

  23. Schett G, Teitelbaum SL. Osteoclasts and arthritis. J Bone Miner Res. 2009;24:1142–6.

    Article  Google Scholar 

  24. Jarrett SJ, Conaghan PG, Sloan VS, et al. Preliminary evidence for a structural benefit of the new bisphosphonate zoledronic acid in early rheumatoid arthritis. Arthritis Rheum. 2006;54:1410–4.

    Article  PubMed  CAS  Google Scholar 

  25. Cohen SB, Dore RK, Lane NE, et al. Denosumab treatment effects on structural damage, bone mineral density, and bone turnover in rheumatoid arthritis: a twelve-month, multicenter, randomized, double-blind, placebo-controlled, phase II clinical trial. Arthritis Rheum. 2008;58:1299–309.

    Article  PubMed  CAS  Google Scholar 

  26. Ideguchi H, Ohno S, Hattori H, Senuma A, Ishigatsubo Y. Bone erosions in rheumatoid arthritis can be repaired through reduction in disease activity with conventional disease-modifying antirheumatic drugs. Arthritis Res Ther. 2006;8:R76.

    Article  PubMed  Google Scholar 

  27. Walsh NC, Reinwald S, Manning CA, et al. Osteoblast function is compromised at sites of focal bone erosion in inflammatory arthritis. J Bone Miner Res. 2009;24:1572–85.

    Article  PubMed  CAS  Google Scholar 

  28. Walsh NC, Gravallese EM. Bone remodeling in rheumatic disease: a question of balance. Immunol Rev. 2010;233:301–12.

    Article  PubMed  CAS  Google Scholar 

  29. Diarra D, Stolina M, Polzer K, et al. Dickkopf-1 is a master regulator of joint remodeling. Nat Med. 2007;13:156–63.

    Article  PubMed  CAS  Google Scholar 

Download references

Disclosure

Dr. Deal has served as a consultant and on the speakers’ bureau for Amgen and Novartis.

Author information

Authors and Affiliations

  1. Center for Osteoporosis and Metabolic Bone Disease, Cleveland Clinic, Cleveland Clinic Lerner College of Medicine at Case Western, University School of Medicine, Cleveland, OH, 44122, USA

    Chad Deal

  2. Orthopaedic and Rheumatologic Institute, Cleveland Clinic, Cleveland Clinic Lerner College of Medicine at Case Western, University School of Medicine, Cleveland, OH, 44122, USA

    Chad Deal

Authors
  1. Chad Deal
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Chad Deal.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Deal, C. Bone Loss in Rheumatoid Arthritis: Systemic, Periarticular, and Focal. Curr Rheumatol Rep 14, 231–237 (2012). https://doi.org/10.1007/s11926-012-0253-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11926-012-0253-7

Keywords

Search

Navigation